Thorax Podcast

Thorax Podcast is a respiratory medicine show anchored in research papers, clinical interpretation, and the systems that shape lung health. It works in a measured editorial lane. The conversations usually begin with a paper, a survey, or a journal club theme, then move toward what the evidence can and cannot support. Recent episodes cover COPD, pulmonary sarcoidosis, sleep and ventilation, asthma medication non-adherence in the USA, azithromycin prescribing, and respiratory trainee workforce concerns in the UK. That range gives the show a distinct shape: disease mechanisms sit beside policy, diagnostics, training, and access to care. It is not a general wellness programme. It assumes comfort with clinical language such as FEV1, CPAP, spirometry, exacerbations, biomarkers, and meta-analysis. The reward is precision. A discussion of prophylactic azithromycin in COPD, for example, stays with patient selection, prediction models, inflammatory markers, and the gap between clinician instinct and trial-derived signals. A conversation on sarcoidosis holds together lung function decline, heterogeneity, restrictive disease, environmental exposure, and racial differences reported in a cohort. The asthma medication episode connects adherence to cost, insurance coverage, health literacy, and policy interventions. Workforce episodes shift the frame again, treating location, supportive teams, flexible working, retention, and consultant job choice as part of respiratory medicine’s future. Kate Diomedi is a recurring named interviewer in several Thorax episodes, with guests positioned through their connection to papers, editorials, or respiratory medicine work. The PulmPEEPs collaborations add a journal club mode, bringing selected articles into a more conversational review format. The pacing is calm but dense. Questions tend to invite explanation rather than argument. Guests are given room to define terms, describe methods, and name uncertainty. The show’s value is its habit of translating publication-level respiratory research into clinical and institutional consequences without pretending the evidence is simpler than it is. It suits a listener who wants serious lung medicine with enough context to follow the study and enough restraint to respect its limits.